Tag: Guy Chamberland

February 24, 2020

Tetra Bio-Pharma Issues Comment on Drug Development

Tetra Bio-Pharma gave investors more details on its drug development program for a candidate after it engaged with the US...
February 3, 2020

Tetra Bio-Pharma Moves Ahead with Fast Track for CAUMZ

Tetra is now able to file for fast track designation for its cannabinoid-based drug CAUMZ, which aims to treat cancer...
January 22, 2020

Tetra Plans 2020 Product Launch, Confirms C$10 Million Offering

Tetra told investors it is moving ahead with a plan to launch its TERPACAN products in Canadian pharmacy retail locations...
December 26, 2019

Cannabis Forecast 2020: Firms Want Investors to Do Their Homework

As another year wraps up, INN spoke with members of the marijuana industry to get their input on what 2020...
December 6, 2019

Cannabis Weekly Round-Up: Drug Maker Gets FDA Boost

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...
December 4, 2019

Tetra Bio-Pharma Secures Orphan Drug Designation from FDA

The upswing for Tetra Bio-Pharma continues as the firm has now confirmed the FDA gave its delta-9-tetrahydrocannabinol drug an orphan...
November 25, 2019

Tetra Bio-Pharma Jumps Thanks to Trial Restoration

Medical marijuana research firm Tetra Bio-Pharma announced its trial for PPP001 was back in place after a review from the...